Bio-Rad Laboratories, Inc. (BIO) compared with its closest peers (A, WAT, ILMN, MTD, RVTY). Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Agilent Technologies, Inc. (A) | $44.17B | 31.2 |
| Waters Corporation (WAT) | $39.76B | 239.3 |
| Illumina, Inc. (ILMN) | $32.21B | 51.5 |
| Mettler-Toledo International Inc. (MTD) | $30.21B | 38.3 |
| Revvity, Inc. (RVTY) | $13.85B | 77.0 |
| Avantor, Inc. (AVTR) | $9.73B | -14.7 |
| Bruker Corporation (BRKR) | $9.13B | -314.1 |
| 10x Genomics, Inc. (TXG) | $8.16B | -46.6 |
| Alamar Biosciences, Inc. (ALMR) | $2.40B | — |
| EyePoint Pharmaceuticals, Inc. (EYPT) | $466.41M | -5.8 |
| Sector P/E (Technology) | 33.9 |
| Industry P/E (Measuring & Control Equipment) | 51.8 |
BIO overview · BIO earnings · BIO financials · BIO KPIs · BIO investor relations · BIO ownership · BIO filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.